Floatz logo

Promethazine

MZL

Institute of Hematology & Blood Diseases Hospital, ChinaSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the MZL cohort.

Asset / SponsorPhaseRating
Apg-2575
Henan Cancer Hospital
Phase 2CCC
Baff-R Car-T
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2CCC
Hmpl-760
Hutchmed
Phase 1CC

Same molecule, other indications

Promethazine is also rated in:

disruptive behavior disorderDormant
BB
Indicative ·
64 / 100
View asset →
migraine without auraDormant
B
Indicative ·
62 / 100
View asset →
physiological malfunction arising from mental factorDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →